Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism DYRK2 inhibitors(dual specificity tyrosine phosphorylation regulated kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | CN | 25 May 2022 |